These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled study. Emamzadehfard S, Kamaloo A, Paydary K, Ahmadipour A, Zeinoddini A, Ghaleiha A, Mohammadinejad P, Zeinoddini A, Akhondzadeh S. Psychiatry Clin Neurosci; 2016 Aug; 70(8):332-41. PubMed ID: 27106362 [Abstract] [Full Text] [Related]
32. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study. Mundo E, Bianchi L, Bellodi L. J Clin Psychopharmacol; 1997 Aug; 17(4):267-71. PubMed ID: 9241005 [Abstract] [Full Text] [Related]
39. Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse. Hollander E, Stein DJ, Fineberg NA, Marteau F, Legault M. J Clin Psychiatry; 2010 Jun; 71(6):784-92. PubMed ID: 20492845 [Abstract] [Full Text] [Related]